Infliximab infusions for Netherton syndrome: sustained clinical improvement correlates with a reduction of thymic stromal lymphopoietin levels in the skin
Published in
Journal of investigative dermatology, vol. 131, no. 9, p. 1947-1950Publication date
2011Keywords
- Adult
- Antibodies, Monoclonal/administration & dosage
- Cytokines/metabolism
- Dermatologic Agents/administration & dosage
- Female
- Humans
- Netherton Syndrome/drug therapy/metabolism/pathology
- Skin/drug effects/metabolism/pathology
Citation (ISO format)
FONTAO, Lionel et al. Infliximab infusions for Netherton syndrome: sustained clinical improvement correlates with a reduction of thymic stromal lymphopoietin levels in the skin. In: Journal of investigative dermatology, 2011, vol. 131, n° 9, p. 1947–1950. doi: 10.1038/jid.2011.124
Main files (1)
Article (Published version)
Identifiers
- PID : unige:25019
- DOI : 10.1038/jid.2011.124
- PMID : 21654837
